Part 01
What telehealth peptides actually require
Peptides marketed for human use are prescription products, not supplements. A compliant program needs four layers working together, and a brand can own none of them directly.
Licensed prescribers
A provider licensed in the patient's state reviews intake, makes a clinical decision, and prescribes only when appropriate.
MyOrbitHealth covers all 50 states with 2,400+ board-certified providers.
503A pharmacy partners
Patient-specific compounded peptides are dispensed by state-licensed 503A pharmacies.
OrbitRx routes prescriptions via Surescripts into a LegitScript-certified pharmacy network.
Eligibility tracking
Which peptides may be compounded changes over time.
Formularies are clinician-governed and reviewed against current FDA compounding lists rather than fixed at launch.
MSO structure
A non-clinician brand cannot practice medicine.
The MSO / friendly-PC structure keeps clinical control with the professional entity while you own brand, marketing, and customers.
Modality rules per state
Some states require a synchronous visit before certain prescribing.
Orbit Intake maps modality requirements per state so patient flow stays compliant automatically.
Ad-platform certification
LegitScript certification is effectively required before Google and Meta will run prescription-adjacent campaigns.
We support your brand's certification path.
Part 02
Legal prescription route vs the gray market
The difference is not marketing language. It is whether a prescriber and a licensed pharmacy sit in the chain.
| Clinical decision | Prescription route: a licensed provider evaluates every patient. Gray market: no provider, vials labeled 'research use only' and marketed with dosing protocols anyway. |
|---|---|
| Fulfillment | Prescription route: state-licensed 503A compounding pharmacy. Gray market: unlicensed reseller with no pharmacy oversight. |
| Payments and ads | Prescription route: processors and ad platforms will work with a LegitScript-certified operation. Gray market: frozen merchant accounts and ad bans are routine. |
| Durability | Prescription route: a company you can scale, raise on, and sell. Gray market: enforcement risk that compounds with every new customer. |
Part 03
What MyOrbitHealth runs for your peptide brand
You keep the brand, the audience, and the customer relationship. We operate the regulated back end.
Orbit Intake
AI-driven adaptive medical intake with severity scoring and red-flag escalation, white-labeled to your brand.
OrbitOS
Clinical console for patients, encounters, prescriptions, and providers, with role-based access and a full HIPAA audit trail.
OrbitRx
EPCS-ready e-prescribing routed via Surescripts into a LegitScript-certified compounding and retail pharmacy network.
Compliance layer
HIPAA with a BAA in every contract, SOC 2 Type II, US-region encrypted PHI, and the operating MSO structure.
Room to expand
Peptide customers convert into TRT, HRT, and GLP-1 programs.
All of those run on the same stack, so expansion is a config change, not a migration.
Developer path
Run the hosted white-label clinic, or embed care in software you already own through a REST API, webhooks, and a React SDK.
